-+ 0.00%
-+ 0.00%
-+ 0.00%
Guess which is ASX 300 healthcare share is storming higher on an 18% revenue boost
Share
Listen to the news

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is charging higher today.

Shares in the residential aged care provider closed on Friday trading for $6.44. In early morning trade on Monday, shares are changing hands for $6.86 apiece, up 6.5%.

For some context, the ASX 300 is up 0.2% at this same time.

Here's why Regis Healthcare shares are outperforming today.

ASX 300 healthcare share jumps on revenue surge

Regis Healthcare shares are lifting off today following the release of the company's half-year earnings results (H1 FY 2026).

Notably, the ASX 300 healthcare share achieved an 18% year on year increase in its revenue from services to $667.7 million.

Management credited the revenue growth to higher AN-ACC (Australian National Aged Care Classification) pricing, improved occupancy, and the company's recent acquisitions of Ti Tree Operations, Rockpool and OC Health. Those acquisitions added a combined eight homes and more than 1,000 beds to Regis Healthcare's national portfolio.

Earnings also lifted, with H1 FY 2026 underlying earnings before interest, taxes, depreciation and amortisation (EBITDA) up 4% to $70.6 million.

And net operating cash flow surged 40% from H1 FY 2025 to $291.7 million. That big boost was driven by net refundable accommodation deposits (RADs) cash inflow of $178.5 million.

On the bottom line, the ASX 300 healthcare share reported underlying net profit after tax (NPAT) of $29.7 million, broadly in line with H1 FY 2025.

Statutory NPAT of $13.4 million was down 45% year on year, impacted by one-off costs that were mostly related to Regis' acquisitions over the six months.

As for passive income, the board declared a fully franked interim dividend of 9 cents per share, up 11.1% from last year's interim payout (which was only 60% franked).

Regis Resources had net cash of $198 million as at 31 December, up 10% year on year.

What did management say?

Commenting on the results boosting the ASX 300 healthcare share today, Regis managing director and CEO Linda Mellors said:

Our half-year results demonstrate the resilience and momentum of the business as we continue to operate in a rapidly evolving operating environment. We remain focused on delivering high-quality care while advancing our growth strategy, supported by high occupancy and continued investment in our people and service offering…

Looking to what's ahead for Regis Healthcare shares, Mellors added:

We have successfully ramped up our Camberwell home in its first year, and we are progressing the greenfield pipeline with Toowong and Carlingford under construction.

At the same time, we continue to invest in strategic initiatives that support the long-term success of the business. With an active pipeline of M&A opportunities and nine greenfield development opportunities, Regis is well-positioned for continued growth.

The post Guess which is ASX 300 healthcare share is storming higher on an 18% revenue boost appeared first on The Motley Fool Australia.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending